Elon Musk's Neuralink received U.S. Food and Drug Administration (FDA) clearance for its first-in-human clinical trial which has been developing a device surgically inserted into the brain by a robot and capable of decoding brain activity and linking it to computers. Up until now, the company has conducted research only in animals. Read more on why this is a critical milestone for the brain-implant startup.